RecruitingEarly Phase 1NCT05247255

Quadratus Lumborum Block for Total Hip Arthroplasty

Quadratus Lumborum (QL) Nerve Block for Patients Undergoing Primary Total Hip Arthroplasty (THA)

Sponsor

University of California, Los Angeles

Enrollment

80 participants

Start Date

Mar 29, 2022

Study Type

INTERVENTIONAL

Conditions

Pain, Postoperative

Summary

The quadratus lumborum (QL) block is a fascial plane block that has been described to provide analgesia from T7-L3 dermatomes. The investigators aim to evaluate the efficacy of QL blocks in patients undergoing primary total hip arthroplasty (THA).

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Active Comparator and a drug called Placebo Comparator for people with pain, postoperative. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.